Controlled release formulation of captopril or a prodrug of capt

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424457, 424463, 424468, 424474, 424475, 514423, A61K 922, A61K 928, A61K 952

Patent

active

057284024

ABSTRACT:
The invention provides a controlled release pharmaceutical unit dose composition for oral administration which comprises: (a) an internal phase which comprises captopril or a prodrug of captopril in admixture with a hydrogel forming agent; and (b) an external phase which comprises a coating which resists dissolution in the stomach.

REFERENCES:
patent: 3065143 (1962-11-01), Christenson et al.
patent: 4046889 (1977-09-01), Ondetti et al.
patent: 4369172 (1983-01-01), Schor et al.
patent: 4389393 (1983-06-01), Schor et al.
patent: 4704285 (1987-11-01), Alderman
patent: 4756911 (1988-07-01), Drost et al.
patent: 4915954 (1990-04-01), Ayer et al.
Metolose SR Brochure ShinEtsu, USP Hydroxypropyl Methylcellulose (1993).
Tech. Info. for Methoccel, Dow Chemical (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Controlled release formulation of captopril or a prodrug of capt does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release formulation of captopril or a prodrug of capt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulation of captopril or a prodrug of capt will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-955497

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.